Status:

COMPLETED

Effect of Out of Plane and In Plane Injection Techniques in Patients With Carpal Tunnel Syndrome

Lead Sponsor:

Istanbul University - Cerrahpasa

Collaborating Sponsors:

Istanbul Training and Research Hospital

Conditions:

Carpal Tunnel Syndrome

Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of this study, using two different injection techniques, 1. To evaluate the patients in terms of the pain they feel during the application of carpal tunnel syndrome (CTS) injection, 2. Evalua...

Detailed Description

Among the evaluated patients, the patients who met the inclusion and exclusion criteria and accepted the carpal tunnel syndrome injection will be randomized into 2 groups using the random numbers tabl...

Eligibility Criteria

Inclusion

  • Age ≥18
  • Numbness and tingling in the median nerve innervation area with or without pain
  • Worsening of symptoms at night
  • Positive Tinel and/or Phalen sign
  • Symptom duration longer than 12 weeks
  • Electrophysiologically mild or moderate CTS being diagnosed.

Exclusion

  • Presence of conditions such as cervical radiculopathy, polyneuropathy, brachial plexopathy, thoracic outlet syndrome that may mimic CTS
  • Presence of multiple entrapment neuropathy
  • Weakness in hand thumb abduction or opposition
  • Thenar atrophy
  • Presence of wrist corticosteroid and/or local anesthetic injection
  • Regular use of medical treatment such as oral corticosteroids or NSAIDs
  • Having entered a physical therapy program due to CTS in the last 6 months before the injection
  • A history of trauma or arthritis attack at the wrist level
  • Previous surgery due to CTS
  • Thyroid diseases, diabetes, chronic kidney failure
  • Having bifid median nerve, persistent median artery, ganglion cyst, tenosynovitis or tendinitis on wrist USG
  • Rheumatological disease (rheumatoid arthritis, ankylosing spondylitis, systemic lupus) erythematosus, vasculitis, systemic sclerosis, dermatomyositis)
  • Presence of malignancy
  • Pregnant or breastfeeding mothers
  • Infection or skin lesion at the injection site
  • Use of wrist splints in the last 4 weeks
  • Allergy to corticosteroids or local anesthetics

Key Trial Info

Start Date :

April 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 21 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05343351

Start Date

April 1 2022

End Date

February 21 2023

Last Update

February 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istanbul Training and Research Hospital

Istanbul, Turkey (Türkiye)